Ondansetron
- Product NDC
- 60760-567
- 11-digit product format
- 607600567
- Labeler code
- 60760
- Product ID
- 60760-567_50c54fee-53c2-3fa2-e063-6394a90ad727
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ondansetron
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Labeler
- ST. MARY'S MEDICAL PARK PHARMACY
- Application
- ANDA090469
- Marketing category
- ANDA
- Marketing start
- 2022-08-25
- Marketing end
- 2026-07-31
- Substance
- ONDANSETRON
- Active strength
- 8 mg/1
- Pharmacologic classes
- Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Ondansetron
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ONDANSETRON | 8 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 4AF302ESOS |
| Rxcui | 312087 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 60760-567-10 | Ondansetron | 10 in 1 BOTTLE, PLASTIC | TABLET, ORALLY DISINTEGRATING | 10 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 60760-567 | ONDANSETRON TABLET, ORALLY DISINTEGRATING [ST. MARY'S MEDICAL PARK PHARMACY] | 1 | Current NDC, Legacy NDC, 1 package rows | 20220914_e8823f01-ad74-0dd0-e053-2a95a90aa315.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 60760-567-10 | 60760056710 | 10 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (60760-567-10) | 2022-08-25 | 2026-07-31 | No | No | Current |